“…With its unique biology, such as early inducement of gametocytes, restriction of invading reticulocytes, which causes low parasitemia that challenges clinical and paraclinical detection, and the ability to trigger hypnozoiteinduced relapses, P. vivax constitutes a key target in the last global battle against malaria (Adams and Mueller, 2017;Bantuchai et al, 2022;Moreno et al, 2022). Although the involvement of some P. vivax-expressed proteins, such as P. vivax Duffy binding protein (PvDBP) (Kar and Sinha, 2022), and most recently P. vivax reticulocyte-binding protein 1a and 1b (PvRBP1a and 1b) (Han et al, 2016), 2a (PvRBP2a) (Malleret et al, 2021), and 2b (PvRBP2b) (Gruszczyk et al, 2018) in reticulocyte invasion are well documented, the mechanism underlying this process remains largely unknown (Molina-Franky et al, 2022). The recent increase in human malaria cases due to a zoonotic malaria parasite, P. knowlesi, with the highest prevalence in Southeast Asia (Jeyaprakasam et al, 2020), has revealed that the pathogen is able to induce severe, fatal disease.…”